D
Aspire Biopharma Holdings, Inc. ASBP
$8.87 -$0.38-4.11% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025 09/30/2025 06/30/2025
Total Cash And Short-Term Investments 107.74% 483.42% -48.47% 844.86% -84.69%
Total Receivables -- -- -- -- --
Inventory -22.03% 46.13% 615.25% -- --
Prepaid Expenses 13.47% 1,515.43% -86.86% -46.45% 26.53%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 89.20% 442.38% -45.40% 142.88% -49.66%

Total Current Assets 89.20% 442.38% -45.40% 142.88% -49.66%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 90.25% 442.38% -45.40% 142.88% -49.66%

Total Accounts Payable 13.31% -15.43% -4.38% -21.51% -5.61%
Total Accrued Expenses -10.21% -41.62% 119.50% -15.21% 8.80%
Short-term Debt -- -71.03% -39.99% 1.79% 25.27%
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -98.85% -- --
Total Other Current Liabilities -- -- -98.85% -- --
Total Current Liabilities -46.51% -58.48% -45.22% 31.29% 19.03%

Total Current Liabilities -46.51% -58.48% -45.22% 31.29% 19.03%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -71.03% -39.99% 1.79% 25.27%
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 0.21% 0.63% 866.67% -79.92% 0.00%
Total Liabilities -45.13% -57.75% -44.57% 30.78% 18.93%

Common Stock & APIC 26.66% 64.49% 88.41% 0.00% -5.80%
Retained Earnings -4.16% -11.82% -20.88% -8.94% -10.58%
Treasury Stock & Other -- -- -- -- --
Total Common Equity 203.94% 160.67% 44.40% -19.24% -38.32%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 203.94% 160.67% 44.40% -19.24% -38.32%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 203.94% 160.67% 44.40% -19.24% -38.32%